Music Breathing in Enhancing Resilience Among Elders at Risk of Mental Health Problems
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorChinese University of Hong Kong
About this trial
The goal of this pilot randomised controlled trial is to examine the effects of a mindfulness-based music breathing intervention in enhancing resilience (primary outcome), and in reducing anxiety, depressive symptoms, loneliness, and improving health-related quality of life (secondary outcomes) among community-dwelling older adults at risk of mental health problems.
It is hypothesised that compared with the control group, participants in the intervention group will report enhanced resilience, reduced anxiety, depressive symptoms, and loneliness, and improved health-related quality of life immediately post-intervention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 65 years or above
Able to read Chinese and communicate in Cantonese/Mandarin.
Has mild to moderate anxiety and/or depressive symptoms, based on the - Hospital Anxiety and Depression Scale (HADS) (i.e., a score of 8 or higher on either the anxiety or depression subscale)
Disqualifiers
Partcipants will be excluded if they have cognitive impairment, hearing loss, severe depression, known mental illness, or chronic illness.
Trial design
Design model
Parallel
Treatments tested in this trial
Mindfulness-based music breathing intervention
BehavioralParticipants in the intervention group will receive a 4-week music plus mindfulness-based breathing program, consisting of one 60-minute face-to-face session per week. The sessions will be delivered in small groups by a qualified music breathing practitioner. The intervention will follow a structured protocol developed by the research team and reviewed by a certified trained music-breathing therapist. Each session will consist of four progressive breathing phases, including: I. Discovery Breathing - to increase awareness of breath and bodily sensations II. Triangular Breathing - to cultivate control and balance through rhythm III. Silent Breathing - to promote stillness and internal reflection IV. Music Breathing - to combine guided music listening with mindful breathing for emotional regulation
control group
BehavioralParticipants in the control group will receive usual care, which may include access to existing community-based services, health education, or leisure activities, but will not involve any structured music or mindfulness-based intervention.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Mindfulness-based music breathing interventionExperimental treatment 1 intervention
Group B: Control groupPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Resilience
Elders' resilience will be measured by the Chinese version of the Connor-Davidson Resilience Scale (CD-RISC). Total scores range from 0 to 100, with higher scores indicating higher level of resilience.
Time frame
Change from baseline to post-intervention (at 4-week follow-up).Secondary outcomes
1
Anxiety and depressive symptoms
The Chinese version of the Hospital Anxiety and Depression Scale (HADS) will be employed to evaluate anxiety and depressive symptoms. Total scores range from 0 to 41, with higher scores indicating high levels of anxiety and depressive symptoms.
Time frame
Change from baseline to post-intervention (at 4-week follow-up).2
Health-related quality of life
The European Quality of Life-5 Dimensions questionnaire (EQ-5D-3L) will be used to evaluate the participants' health-related quality of life. The visual analogue scale will be used to measure the participant's perception of their overall health status from 0 to 100, with 0 being the worst imaginable health and 100 the best health.
Time frame
Change from baseline to post-intervention (at 4-week follow-up).3
Loneliness
The UCLA Loneliness Scale will be used to assess elders' levels of loneliness. Total score ranges from 20 to 80. A higher total score indicates a greater degree of subjective loneliness and social isolation.
Time frame
Change from baseline to post-intervention (at 4-week follow-up).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov